Validation of a gene expression signature for assessment of lymph node metastasis in oral squamous cell carcinoma.

PURPOSE Current assessment of lymph node metastasis in patients with head and neck squamous cell carcinoma is not accurate enough to prevent overtreatment. The aim of this study was validation of a gene expression signature for distinguishing metastasizing (N+) from nonmetastasizing (N0) squamous cell carcinoma of the oral cavity (OSCC) and oropharynx (OPSCC) in a large multicenter cohort, using a diagnostic DNA microarray in a Clinical Laboratory Improvement Amendments/International Organization for Standardization-approved laboratory. METHODS A multigene signature, previously reported as predictive for the presence of lymph node metastases in OSCC and OPSCC, was first re-evaluated and trained on 94 samples using generic, whole-genome, DNA microarrays. Signature genes were then transferred to a dedicated diagnostic microarray using the same technology platform. Additional samples (n=222) were collected from all head and neck oncologic centers in the Netherlands and analyzed with the diagnostic microarray. Human papillomavirus status was determined by real-time quantitative polymerase chain reaction. RESULTS The negative predictive value (NPV) of the diagnostic signature on the entire validation cohort (n=222) was 72%. The signature performed well on the most relevant subset of early-stage (cT1-T2N0) OSCC (n=101), with an NPV of 89%. CONCLUSION Combining current clinical assessment with the expression signature would decrease the rate of undetected nodal metastases from 28% to 11% in early-stage OSCC. This should be sufficient to enable clinicians to refrain from elective neck treatment. A new clinical decision model that incorporates the expression signature is therefore proposed for testing in a prospective study, which could substantially improve treatment for this group of patients.

[1]  C. Perou,et al.  Molecular classification of head and neck squamous cell carcinomas using patterns of gene expression. , 2004, Cancer cell.

[2]  L. Smeele,et al.  Ultrasound‐guided aspiration cytology for the assessment of the clinically N0 neck: Factors influencing its accuracy , 2008, Head & neck.

[3]  J. Werner,et al.  Extent of surgical intervention in case of N0 neck in head and neck cancer patients: an analysis of data collection of 39 hospitals , 2004, European Archives of Oto-Rhino-Laryngology and Head & Neck.

[4]  Ruud H. Brakenhoff,et al.  The molecular biology of head and neck cancer , 2011, Nature Reviews Cancer.

[5]  P. Bradley,et al.  Neck treatment and shoulder morbidity: Still a challenge , 2011, Head & neck.

[6]  Farin Kamangar,et al.  Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[7]  Christine H Chung,et al.  Human Papillomavirus in Head and Neck Cancer: Its Role in Pathogenesis and Clinical Implications , 2009, Clinical Cancer Research.

[8]  Carole Fakhry,et al.  Case-control study of human papillomavirus and oropharyngeal cancer. , 2007, The New England journal of medicine.

[9]  A. Witteveen,et al.  Converting a breast cancer microarray signature into a high-throughput diagnostic test , 2006, BMC Genomics.

[10]  J. Shah,et al.  Early stage squamous cell cancer of the oral tongue—clinicopathologic features affecting outcome , 2012, Cancer.

[11]  A. Chalian,et al.  Management of clinically negative neck for the patients with head and neck squamous cell carcinomas in the modern era. , 2008, Oral oncology.

[12]  J. Stockman.  Human Papillomavirus and Survival of Patients with Oropharyngeal Cancer , 2012 .

[13]  M. Karamouzis,et al.  Head and neck cancer , 2008, The Lancet.

[14]  W. Dinjens,et al.  A subset of head and neck squamous cell carcinomas exhibits integration of HPV 16/18 DNA and overexpression of p16INK4A and p53 in the absence of mutations in p53 exons 5–8 , 2003, International journal of cancer.

[15]  J. Roodenburg,et al.  Morbidity of the neck after head and neck cancer therapy , 2004, Head & neck.

[16]  I. Jurisica,et al.  Molecular classification of oral cancer by cDNA microarrays identifies overexpressed genes correlated with nodal metastasis , 2004, International journal of cancer.

[17]  Patrick Kemmeren,et al.  Multiple robust signatures for detecting lymph node metastasis in head and neck cancer. , 2006, Cancer research.

[18]  M. Kogo,et al.  Decision analysis and treatment threshold in a management for the N0 neck of the oral cavity carcinoma. , 2009, Oral oncology.

[19]  T. Song,et al.  Elective neck dissection or "watchful waiting": optimal management strategy for early stage N0 tongue carcinoma using decision analysis techniques. , 2008, Chinese medical journal.

[20]  P. D. de Wilde,et al.  Assessment of preoperative ultrasonography of the neck and elective neck dissection in patients with oral squamous cell carcinoma. , 2010, Oral oncology.

[21]  Eric M. Genden,et al.  Contemporary management of cancer of the oral cavity , 2010, European Archives of Oto-Rhino-Laryngology.

[22]  Philip Lijnzaad,et al.  An expression profile for diagnosis of lymph node metastases from primary head and neck squamous cell carcinomas , 2005, Nature Genetics.

[23]  Sunil Singhal,et al.  Gene expression signature predicts lymphatic metastasis in squamous cell carcinoma of the oral cavity , 2005, Oncogene.

[24]  A. Hui,et al.  Comparative prognostic value of HPV16 E6 mRNA compared with in situ hybridization for human oropharyngeal squamous carcinoma. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[25]  S. Khuder,et al.  Elective management of the clinically negative neck by otolaryngologists in patients with oral tongue cancer. , 2003, Archives of otolaryngology--head & neck surgery.

[26]  J. Shah,et al.  Management of the clinically negative neck in early‐stage head and neck cancers after transoral resection , 2011, Head & neck.

[27]  Isabel Beichl,et al.  Watchful Waiting , 2011, Comput. Sci. Eng..

[28]  K. Owzar,et al.  Sentinel lymph node biopsy accurately stages the regional lymph nodes for T1-T2 oral squamous cell carcinomas: results of a prospective multi-institutional trial. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[29]  T. Poli,et al.  Sentinel Node Biopsy in Head and Neck Squamous Cell Cancer: 5-Year Follow-Up of a European Multicenter Trial , 2010, Annals of Surgical Oncology.

[30]  R. Bernards,et al.  Enabling personalized cancer medicine through analysis of gene-expression patterns , 2008, Nature.

[31]  A. Psyrri,et al.  Human papillomavirus-related head and neck tumors: clinical and research implication , 2009, Current opinion in oncology.